报价延迟最少15分钟:2026/07/04 18:25 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
13.65 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.62/--
|
|
企业价值
445.63M
|
| 资产负债 |
|
每股账面净值
-5.05
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
32.04M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States. |
